Method for treating delayed-type hypersensitivity
AssigneeCLS Therapeutics Limited
InventorsDmitry Dmitrievich Genkin, Georgy Viktorovich Tets, Viktor Veniaminovich Tets
Life of this patent
Estimating the term…
Abstract
The invention is directed to treatment of delayed-type hypersensitivity reactions associated with changes of qualitative and/or quantitative composition of blood extracellular DNA and treatment of systemic DNA mutation diseases accompanied with development of somatic mosaicism and elevation of blood extracellular DNA. The inventive method comprises introducing a DNASE enzyme into the systemic blood circulation of a patient in doses and regimens which are sufficient to decrease average molecular weight of circulating extracellular blood DNA in the blood of said patient.
Claims3
A method for treating delayed-type hypersensitivity reactions associated with changes of qualitative and/or quantitative composition of blood extracellular DNA in a patient in need thereof, wherein said method comprises introducing a DNase enzyme into the systemic blood circulation of said patient.
Dependencies are inferred from the claim text.